This trial will compare cancer detection rates of two types of mammograms, one with and one without contrast enhancement.
- Breast Cancer
1 Primary · 1 Secondary · Reporting Duration: 48 months
1 Treatment Group
1 of 1
1650 Total Participants · 1 Treatment Group
Primary Treatment: Contrast-enhanced mammogram · No Placebo Group · N/A
Who is running the clinical trial?
Age 30 - 85 · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the estimated enrollment rate for this experiment?
"Affirmative. According to the info on clinicaltrials.gov, this study is still seeking participants which it initially posted for in October 2019 and more recently updated in September 2022. The trial requires 1650 people from 3 different locations to take part." - Anonymous Online Contributor
May I qualify to take part in this medical trial?
"In order to be eligible, individuals must have a diagnosis of breast cancer and be aged between 30 and 85. This trial aims to recruit approximately 1650 participants." - Anonymous Online Contributor
Are there any opportunities still available for participation in this experiment?
"That is correct. Clinicaltrials.gov attests that this investigation, which was first advertised on October 23rd 2019, is actively recruiting participants. 1,650 individuals are needed from three distinct clinical locations to take part in the trial." - Anonymous Online Contributor
Does this research endeavor offer opportunities for individuals aged 45 and above?
"This particular clinical research effort is searching for participants between the ages of 30 and 85. Those younger than that age threshold can look to 370 alternative trials, while those older have access to 4,568 studies." - Anonymous Online Contributor